A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC): Updated results

E. E.W. Cohen; K. J. Harrington; D. S. Hong; R. Mesia; I. Brana; P. Perez Segura; T. Wise-Draper; M. L. Scott; P. D. Mitchell; G. M. Mugundu; P. McCoon; C. E. Cook; M. Mehta; U. Keilholz

doi:10.1093/annonc/mdy287

A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC): Updated results

E. E.W. Cohen, K. J. Harrington, D. S. Hong, R. Mesia, I. Brana, P. Perez Segura, T. Wise-Draper, M. L. Scott, P. D. Mitchell, G. M. Mugundu, P. McCoon, C. E. Cook, M. Mehta, U. Keilholz

Investigational Cancer Therapeutics

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	viii372
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy287
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy287

Cite this

Cohen, E. E. W., Harrington, K. J., Hong, D. S., Mesia, R., Brana, I., Perez Segura, P., Wise-Draper, T., Scott, M. L., Mitchell, P. D., Mugundu, G. M., McCoon, P., Cook, C. E., Mehta, M., & Keilholz, U. (2018). A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC): Updated results. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii372. https://doi.org/10.1093/annonc/mdy287

A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC): Updated results. / Cohen, E. E.W.; Harrington, K. J.; Hong, D. S. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii372.

Research output: Contribution to journal › Article › peer-review

Cohen, EEW, Harrington, KJ, Hong, DS, Mesia, R, Brana, I, Perez Segura, P, Wise-Draper, T, Scott, ML, Mitchell, PD, Mugundu, GM, McCoon, P, Cook, CE, Mehta, M & Keilholz, U 2018, 'A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC): Updated results', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii372. https://doi.org/10.1093/annonc/mdy287

Cohen EEW, Harrington KJ, Hong DS, Mesia R, Brana I, Perez Segura P et al. A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC): Updated results. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii372. doi: 10.1093/annonc/mdy287

Cohen, E. E.W. ; Harrington, K. J. ; Hong, D. S. et al. / A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC) : Updated results. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018 ; Vol. 29. pp. viii372.

@article{4a63d684f0174074ac0cc67b412ce893,

title = "A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC): Updated results",

author = "Cohen, {E. E.W.} and Harrington, {K. J.} and Hong, {D. S.} and R. Mesia and I. Brana and {Perez Segura}, P. and T. Wise-Draper and Scott, {M. L.} and Mitchell, {P. D.} and Mugundu, {G. M.} and P. McCoon and Cook, {C. E.} and M. Mehta and U. Keilholz",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy287",

language = "English (US)",

volume = "29",

pages = "viii372",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC)

T2 - Updated results

AU - Cohen, E. E.W.

AU - Harrington, K. J.

AU - Hong, D. S.

AU - Mesia, R.

AU - Brana, I.

AU - Perez Segura, P.

AU - Wise-Draper, T.

AU - Scott, M. L.

AU - Mitchell, P. D.

AU - Mugundu, G. M.

AU - McCoon, P.

AU - Cook, C. E.

AU - Mehta, M.

AU - Keilholz, U.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081529056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081529056&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy287

DO - 10.1093/annonc/mdy287

M3 - Article

C2 - 32136905

SN - 0923-7534

VL - 29

SP - viii372

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC): Updated results

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this